InvestorsHub Logo

obryanjfg

01/19/20 11:12 AM

#242295 RE: MontanaState83 #242292

That growth would be outstanding and is pretty much not going to happen. form 400M to 1.5B. I don't think so!

Biobillionair

01/19/20 11:43 AM

#242303 RE: MontanaState83 #242292

MS: For biotechs I use 5x sales and for AMRN shares I round up to 390 million (slide 21 here: https://investor.amarincorp.com/static-files/c2473067-dcab-47ea-9968-b908da51c671)

People will argue 5x sales, but I believe this is a conservative valuation, right now we are ~ 18x sales using $425m for 2019

$700m for 2020 5x sales ~ PPS ~$8.90 which is Oppenheimer crap. The market will more clearly set a multiple as Amarin moves to cash positive.

JMO
BB

I believe Amarin could have peak sales of $15bn as soon as 2025, 5x sales is ~PPS $192.

My target for AMRN by 2025 is $200 PPS and has been for years.